Daniel Joseph OConnell, CEO: Acumen Pharmaceuticals ABOS Planned sale · Filed 01/22

Trade details

Type: Planned sale notice
Stock: Acumen Pharmaceuticals ABOS
Person: Daniel Joseph OConnellCEO
Planned sale date: 26/01/22
Filed: 26/01/22

More to sell after $158.1K in 3 months

Acumen Pharmaceuticals trades, last 26 weeks

What else happened in Acumen Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/12/23~02/21

Daniel Joseph OConnell's recent trades

Daniel Joseph OConnellCEO
SellAcumen Pharmaceuticals
Sell
Acumen Pharmaceuticals
ABOS
$16.9K
9,346 sh
$16.9K
Filed 01/23
Traded 01/21
Daniel Joseph OConnellCEO
SellAcumen Pharmaceuticals
Sell
Acumen Pharmaceuticals
ABOS
$5,055
2,689 sh
$5,055
Filed 01/23
Traded 01/22
Daniel Joseph OConnellCEO
Planned sale10b5-1 planAcumen Pharmaceuticals
Planned sale10b5-1 plan
Acumen Pharmaceuticals
ABOS
$16.9K
9,346 sh
$16.9K
Filed 01/21
Traded 01/21
Daniel Joseph OConnellCEO
SellAcumen Pharmaceuticals
Sell
Acumen Pharmaceuticals
ABOS
$22.8K
12,941 sh
$22.8K
Filed 01/12
Traded 01/09
Daniel Joseph OConnellCEO
SellAcumen Pharmaceuticals
Sell
Acumen Pharmaceuticals
ABOS
$14.8K
8,143 sh
$14.8K
Filed 01/12
Traded 01/08

Daniel Joseph OConnell, CEO — plans to sell 2,689 sh of Acumen Pharmaceuticals ABOS · $5,066 · around 01/22 · 10b5-1 plan | Whalegun